Anacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor used as an active pharmaceutical ingredient. It increases serum HDL-cholesterol levels and decreases LDL-cholesterol levels by reducing cholesteryl ester transfer from HDL to LDL or VLDL.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 875446-37-0
Melanostatine 2
Growth hormone releasing peptide
Atenolol impurity D
beta-blocker impurity reference standard
Trandolapril
active pharmaceutical ingredient
3-(1-Piperazinyl)-1,2-benzisothiazole
active pharmaceutical ingredient
(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one
MZZLGJHLQGUVPN-HAWMADMCSA-N
C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F